Atlas Trials

Phase I Study of FXS887 in the Treatment of Solid Tumors

Clinical trial NCT07345637 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07345637
Sponsor
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor Refractory to Conventional Treatment
Start date
2026-01-05
Primary completion
2027-04-28
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.